91 results
Page 3 of 5
F-3
dlys azjra0z
30 Dec 20
Shelf registration (foreign)
4:17pm
6-K
wsr5zz5 h0sqmx
24 Nov 20
Current report (foreign)
12:00am
424B3
bxq 101ak
16 Nov 20
Prospectus supplement
7:15am
6-K
p5p8rvyod
16 Nov 20
Current report (foreign)
7:00am
6-K
EX-99.2
gy2sy4 vqn
19 Oct 20
Current report (foreign)
4:10pm
6-K
EX-99.1
ri1rajo nl
19 Oct 20
Current report (foreign)
4:10pm
424B3
pphs3nmx72sla3s
26 Aug 20
Prospectus supplement
5:21pm
6-K
2m73ny acxhupan
13 Aug 20
Current report (foreign)
7:00am
6-K
ic9pyeab0
31 Jul 20
Current report (foreign)
12:00am
6-K
EX-99.2
wes4oi95d
28 May 20
Notice of Annual General Meeting of Shareholders
9:14am
6-K
EX-99.1
7j62nm26iva
28 May 20
Notice of Annual General Meeting of Shareholders
9:14am
6-K
rmq hcnbhdx5
14 May 20
Current report (foreign)
7:25am
6-K
EX-4.1
ukvisk8 kijblzmv8
12 May 20
Current report (foreign)
12:04pm
6-K
EX-10.1
oqmdl7u293is6uq
12 May 20
Current report (foreign)
12:04pm
424B5
6gubugmz507vav
12 May 20
Prospectus supplement for primary offering
12:02pm
6-K
EX-10.1
95p5mojam7
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
6-K
EX-4.1
ln4h3lu6 ytgb99
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
424B5
uwzo 0a9bn7hvnz2y
11 May 20
Prospectus supplement for primary offering
9:23am